生理学上稳定,皮层印制,双门金属有机框架药物输送系统用于瘤向组合疗法
Xingkun Luan1, Xin Jin1, Xiaona Li1
1State Key Laboratory of Coordination Chemistry, MOE Key Laboratory of Mesoscopic Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, People's Republic of China.
ACS applied materials & interfaces
|May 29, 2025
概括
我们开发了一种稳定,双门的纳米金属有机框架 (MOF) 用于向癌症治疗. 该系统精确地提供两种化疗药物,并使光动力疗法 (PDT) 能够提高治疗效率.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 纳米级金属有机框架 (MOFs) 对药物输送有希望,但在生理条件下缺乏稳定性.
- 富含酸盐的环境会降解MOF,限制其临床使用.
- 积极向的传递系统对于个性化癌症疗法至关重要.
研究的目的:
- 创建一个生理稳定的,表位印记的,双门的MOF药物递送系统.
- 为了使瘤向组合疗法使用光动力学疗法 (PDT) 和两种药物化学疗法.
- 加强药物向并实现逻辑关闭释放,以精确治疗癌症.
主要方法:
- 功能化PCN-224 (((ZrIV) MOFs与西兰酸盐和加载药物I.
- 利用DNA作为一个门卫 (纳米门I) 和纳米载体的药物II通过介质.
- 组装的ZIF-8膜 (nanogate II) 用于酸盐耐药性和癌细胞识别.
主要成果:
- 双门MOF系统表现出极好的生理稳定性.
- 通过印制的ZIF-8膜实现了对癌细胞的选择性向.
- 尽量减少药物过早泄漏,并启用逻辑关闭释放以提高化疗疗效.
结论:
- 开发的双门MOF药物系统提供了卓越的生理稳定性和积极向癌细胞.
- 成功实现了PDT和两种药物化疗的联合治疗.
- 在癌症基因疗法和核酸疫苗开发中具有广泛的应用前景.
相关概念视频
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


